Treatment for Canine Babesiosis: 40 Cases
World Small Animal Veterinary Association World Congress Proceedings, 2007
Ming-Yu Lin; Shi-Yang Wu; Hui-Pi Huang
Section of Small Animal Internal Medicine, National Taiwan University Veterinary Hospital
Taipei, Taiwan

Background

Canine babesiosis is the most common tick-borne disease in Taiwan.

Aims

The aims of this study were to report efficacy of treatment for canine babesiosis.

Methods

Medical records of canine babesiosis from 2005 to 2006 were reviewed. The diagnosis of canine babesiosis was based on history of tick infestation, presence of anemia, and identification of Babesia gibsoni in the blood smears.

Results

Babesiosis was diagnosed in 40 cases. The age of these dogs ranged from 9 months to 14 years with mean age of 5.3 year old. Maltese was the most common breed and accounted for 25% of all cases. The ratio of male to female was 3:1 in this study. Most cases revealed macrocytic anemia (50%). Twenty-nine dogs received combination of Diminazene aceturate and doxycycline. The average of recovery time in this group was 3.9 weeks. Eleven dogs received combination of doxycycline, metronidazole and enrofloxacin, with the average of recovery time of 3.25 weeks. There was no significant difference in the recovery time between these two groups (p = 0.59).

Conclusion

This study suggested that efficacy of two combinations in treating canine babesiosis (Babesia gibsoni) was similar.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Ming-Yu Lin
National Taiwan University Veterinary Hospital
Taiwan


MAIN : Abstracts - Poster : Canine Babesiosis
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27